Researchers on why DEA should reject HHS cannabis rescheduling recommendations

Abstract

Why shouldn't we reschedule cannabis? This is a question being bandied about from within the National Institute on Drug Abuse (NIDA), which wants to be able to study it, and in fact the entire Department of Health and Human Services (HHS), which in 2023 asked the Drug Enforcement Administration (DEA) to do just that.